Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cells

被引:34
作者
Blume, Lawrence C. [1 ]
Eldeeb, Khalil [1 ]
Bass, Caroline E. [1 ]
Selley, Dana E. [2 ]
Howlett, Allyn C. [1 ]
机构
[1] Wake Forest Univ Hlth Sci, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA
[2] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
关键词
CB1; receptor; CRIP1a; cAMP; ERK1/2; G protein; Endocannabinoid; ADENYLATE-CYCLASE; TYROSINE KINASES; INVERSE AGONIST; BRAIN; TRANSDUCTION; PHARMACOLOGY; ASSOCIATION; ENDOCYTOSIS; INHIBITION; ACTIVATION;
D O I
10.1016/j.cellsig.2014.11.006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
CBI cannabinoid receptors (CB1R) are one of the most abundantly expressed G protein coupled receptors (GPCR) in the CNS and regulate diverse neuronal functions. The identification of GPCR interacting proteins has provided additional insight into the fine-tuning and regulation of numerous GPCRs. The cannabinoid receptor interacting protein 1a (CRIP1a) binds to the distal carboxy terminus of CB1R, and has been shown to alter CB1R-mediated neuronal function [1]. The mechanisms by which CRIP1a regulates CB1R activity have not yet been identified; therefore the focus of this investigation is to examine the cellular effects of CRIP1a on CB1R signaling using neuronal N18TG2 cells stably transfected with CRIP1a over-expressing and CRIP1a knockdown constructs. Modulation of endogenous CRIP1 a expression did not alter total levels of CB1R, ERK, or forskolin-activated adenylyl cyclase activity. When compared to WT cells, CRIP1a over-expression reduced basal phosphoERK levels, whereas depletion of CRIP1a augmented basal phosphoERK levels. Stimulation of phosphoERK by the CB1R agonists WIN55212-2, CP55940 or methanandamide was unaltered in CRIP1a over-expressing clones compared with WT. However, CRIP1 a knockdown clones exhibited enhanced ERIC phosphorylation efficacy in response to CP55940. In addition, CRIP1a knockdown clones displayed a leftward shift in CP55940-mediated inhibition of forskolin-stimulated cAMP accumulation. CB1R-mediated G(i3) and G(o) activation by CP99540 was attenuated by CRIP1a over-expression, but robustly enhanced in cells depleted of CRIP1a. Conversely, CP55940-mediated and G(i2) activation was significant enhanced in cells over-expressing CRIP1a, but not in cells deficient of CRIP1a. These studies suggest a mechanism by which endogenous levels of CRIP1a modulate CB1R-mediated signal transduction by facilitating a G(i/o) protein subtype preference for G(i1) and G(i2), accompanied by an overall suppression of G-protein-mediated signaling in neuronal cells. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:716 / 726
页数:11
相关论文
共 50 条
  • [31] Type-1 (CB1) Cannabinoid Receptor Promotes Neuronal Differentiation and Maturation of Neural Stem Cells
    Compagnucci, Claudia
    Di Siena, Sara
    Bustamante, Maria Blaire
    Di Giacomo, Daniele
    Di Tommaso, Monia
    Maccarrone, Mauro
    Grimaldi, Paola
    Sette, Claudio
    PLOS ONE, 2013, 8 (01):
  • [32] MicroRNA let-7d is a target of cannabinoid CB1 receptor and controls cannabinoid signaling
    Chiarlone, Anna
    Boerner, Christine
    Martin-Gomez, Laura
    Jimenez-Gonzalez, Ada
    Garcia-Concejo, Adrian
    Garcia-Bermejo, Maria L.
    Lorente, Mar
    Blazquez, Cristina
    Garcia-Taboada, Elena
    de Haro, Amador
    Martella, Elisa
    Hoellt, Volker
    Rodriguez, Raquel
    Galve-Roperh, Ismael
    Kraus, Juergen
    Guzman, Manuel
    NEUROPHARMACOLOGY, 2016, 108 : 345 - 352
  • [33] Opposed cannabinoid 1 receptor (CB1R) expression in the prefrontal cortex vs. nucleus accumbens is associated with alcohol consumption in male rats
    Amancio-Belmont, Octavio
    Becerril Melendez, Alline L.
    Ruiz-Contreras, Alejandra E.
    Mendez-Diaz, Monica
    Prospero-Garcia, Oscar
    BRAIN RESEARCH, 2019, 1725
  • [34] CB1 cannabinoid receptors promote maximal FAK catalytic activity by stimulating cooperative signaling between receptor tyrosine kinases and integrins in neuronal cells
    Dalton, George D.
    Peterson, Lynda J.
    Howlett, Allyn C.
    CELLULAR SIGNALLING, 2013, 25 (08) : 1665 - 1677
  • [35] Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery?
    Smith, Tricia H.
    Sim-Selley, Laura J.
    Selley, Dana E.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (03) : 454 - 466
  • [36] Pharmacophore and 3D-QSAR Studies on 1-Sulfonyl-4-acylpiperazines as Selective Cannabinoid-1 Receptor (CB1R) Inverse Agonists
    Telvekar, Vikas N.
    Thakur, Lalit B.
    Jagdhane, Prashant B.
    Manohar, Yogesh D.
    LETTERS IN DRUG DESIGN & DISCOVERY, 2011, 8 (07) : 659 - 670
  • [37] CB1 cannabinoid receptor-G protein association:: a possible mechanism for differential signaling
    Mukhopadhyay, S
    Shim, JY
    Assi, AA
    Norford, D
    Howlett, AC
    CHEMISTRY AND PHYSICS OF LIPIDS, 2002, 121 (1-2) : 91 - 109
  • [38] A quantitative pharmacology model for cannabinoid CB1 receptor mediated by Gi/Gs protein competition
    Yang, Liang
    Finlay, David B.
    Green, Hayley M.
    Zhu, Xiao
    Glass, Michelle
    Duffull, Stephen
    BRITISH JOURNAL OF PHARMACOLOGY, 2024, 181 (08) : 1324 - 1340
  • [39] Revisiting CB1 cannabinoid receptor detection and the exploration of its interacting partners
    Esteban, Pedro F.
    Garcia-Ovejero, Daniel
    Paniagua-Torija, Beatriz
    Moreno-Luna, Rafael
    Arredondo, Luis F.
    Zimmer, Andreas
    Arevalo Martin, Angel
    Molina-Holgado, Eduardo
    JOURNAL OF NEUROSCIENCE METHODS, 2020, 337
  • [40] A Critical Evaluation of Terpenoid Signaling at Cannabinoid CB1 Receptors in a Neuronal Model
    Dvorakova, Michaela
    Wilson, Sierra
    Corey, Wesley
    Billingsley, Jenna
    Zimmowitch, Anaelle
    Tracey, Joye
    Straiker, Alex
    Mackie, Ken
    MOLECULES, 2022, 27 (17):